Connect with us

Technology

BioWorld by Clarivate Highlights Gaps in Women’s Health Research and Investment in New Special Series

Published

1 year ago

on

New seven-part series explores disparities in care, funding and innovation impacting half the world’s population

LONDON, Nov. 21, 2024 /PRNewswire/ — BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has launched its new special series, ‘Healing the Health Divide.‘ This seven-part series sheds light on the persistent disparities in women’s health research, funding, and treatment.

Women make up half of the global population, yet their health remains consistently underserved. Research and treatments have traditionally focused on reproduction and breast health, but these areas represent just a fraction of the broader health challenges women face. From autoimmune disorders to cardiovascular disease, many conditions disproportionately affect women or manifest differently than in men. However, decades of research have excluded women from clinical trials, often due to misconceptions about their “complex physiology.” Meanwhile, male-dominated boardrooms have perpetuated this oversight in funding decisions, exacerbating the issue.

The consequences of this systemic neglect are stark. In 2023, just 15% of venture capital funding was directed to biopharma companies focused on women’s health, and only 8% of funded companies included women’s health assets in their pipelines. These disparities leave critical gaps in care for conditions such as Alzheimer’s disease, which affects women at twice the rate of men, and endometriosis, which impacts approximately 190 million women worldwide, yet often goes undiagnosed for years.

Lynn Yoffee, Publisher of BioWorld, stated: “The new BioWorld special series, ‘Healing the Health Divide,’ is a call to action to address the inequities in women’s health research and investment. The data we’ve uncovered highlights the urgent need for a paradigm shift in how we approach this critical issue. This series not only exposes the disparities but also celebrates the progress being made, with the goal of inspiring industry leaders and scientists to close these gaps and create solutions that benefit all of humanity.”

The series explores underrecognized areas such as the role of gender bias in research, the untapped potential of women’s health markets, and groundbreaking efforts to improve early diagnosis and treatment of conditions like endometriosis and cardiovascular disease.

Featured articles in ‘Healing the Health Divide,’ include:

Despite women’s health inroads, lackluster funding impedes progress 
Despite increased interest, progress in women’s health remains hindered by lackluster funding and decades of exclusion from clinical trials. The number of deals focused on women’s health since 2019 comprise just 18.5% of all deals analyzed from the 473 companies and they make up just 20% of the total value of all deals that disclosed terms. This article, by Senior Managing Editor Karen Carey explores the inspiring efforts of women leading the charge to improve health outcomes and secure investments for female-focused solutions.Dynamic infographic on Women’s Health 
A compelling visual analysis by Production Editor Ann Marie Griffith of women’s health funding, showcases how venture capital and biopharma companies are beginning to address the vast unmet need — but still have far to go.VCs emerge for women’s health and its ‘groundbreaking’ research
While U.S. government initiatives are supportive, private market investments are essential to advance women’s health innovations. This article highlights emerging venture capital efforts and the challenges of securing funding.The science of gender-based medicine: many reasons, many manifestations
From Alzheimer’s to autoimmune diseases, Managing Editor Anette Breindl, examines how biological and hormonal differences impact disease prevalence and progression in women, emphasizing the importance of gender-specific medical research.Gender bias leaves women at risk in cardiology treatment guidelines
Gender bias in cardiac care has left nearly 70% of women underdiagnosed for cardiovascular disease. Staff Writer Tamra Sami investigates how male-focused clinical trials have skewed treatment guidelines, endangering women’s lives.Holistic strategies needed to diagnose and treat endometriosis
Endometriosis affects 10% of women globally, yet delayed diagnosis and limited understanding have left millions suffering unnecessarily. This article, also produced by Sami, delves into the biological complexity of the disease and the need for comprehensive treatment strategies.New diagnostics, trials address deadly disparities in women’s cardiac care
While women with “big hearts” play well in popular culture, cardiologists see a very different picture – with significant implications for women’s health and medical care, according to an article by Editor Annette Boyle. Women have smaller hearts and smaller blood vessels than men and their cardiovascular systems respond to disease and treatment in very different ways. In 2024, for the first time, major trials of cardiovascular medical devices sought to understand how common interventions work in women and how previous failures to include women in studies translated into higher cardiovascular mortality rates.

BioWorld’s “Healing the Health Divide” underscores the urgent need for equitable investment in women’s health and celebrates the pioneers driving meaningful change.

To access the full special series, visit https://www.bioworld.com/womens_health.

Join the conversation and mention BioWorld on X and LinkedIn as well as Clarivate for Life Sciences & Healthcare on X and LinkedIn. 

About BioWorld

With writers and editors stationed around the globe, BioWorld published by Clarivate, reports the breaking news – and provides key perspective on hundreds of therapeutics and devices in development, the companies behind those candidates, the business development transactions that evolve the markets, and the regulatory hurdles that both challenge and guard the processes. BioWorld has a long tradition of excellence in journalism. Collectively, the news services have been honored with 61 awards dating back to 1998.

About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

Media Contact 
Catherine Daniel
Director, External Communications, Life Sciences & Healthcare, Clarivate
newsroom@clarivate.com

SOURCE Clarivate Plc

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

World IP Day 2026: PitchMark launches Ideas.Exchange to help creators safeguard and license ideas in the age of AI

Published

2 hours ago

on

April 26, 2026

By

SINGAPORE, April 26, 2026 /PRNewswire/ — To mark World IP Day 2026, PitchMark® today launched Ideas.Exchange, a first‑of‑its‑kind platform designed to help creators assert intellectual property rights, license ideas, and formalise creative conversations in an increasingly AI‑driven economy.

Unveiled at Safeguard Your IP in the Age of AI, a media briefing hosted by CNBC’s Sri Jegarajah, the platform responds to growing concern that ideas are routinely used, reused or absorbed without attribution, consent or compensation—often with limited legal or commercial recourse.

“AI has amplified both the reach and the risk for creators,” said Mark Laudi, Managing Partner of PitchMark LLP. “Ideas.Exchange gives creators a way to protect themselves while still participating confidently in the market for ideas.”

At its core, the platform focuses on three interventions for creators:

Asserting IP rights by establishing proof of authorship and precedenceLicensing ideas without giving them away for freeFormalising conversations so pitches and evaluations are governed rather than informal

Ideas.Exchange is powered by three proprietary resources developed by PitchMark. These include a blockchain‑driven clearing house where ideas and creative works can be listed and licensed; smart contracts that automate usage terms and reduce disputes; and an IP Governance Certification Program designed to signal responsible handling of ideas, particularly in enterprise and AI contexts.

The result, PitchMark says, is three concrete outcomes: deterrence of idea theft, new ways to monetise ideas through structured licensing and price discovery, and a more level playing field that allows creators to pitch to clients and platforms on equal terms.

The launch comes amid renewed scrutiny of how intellectual property is treated in the AI era. While idea theft is rarely reported, its impact is significant. Beyond visible financial losses, organisations and creators often absorb hidden costs through talent attrition, innovation suppression and abandoned market opportunities.

“Most idea theft occurs informally and never reaches the courts,” said Prof David Llewelyn, Professor Emeritus of Law at Singapore Management University. “Introducing governance, traceability and standards is a meaningful step toward addressing that gap.”

Spokespeople including Prof Llewelyn, technology lawyer Bryan Ghows, and Mark Laudi are available for interview.

About PitchMark

PitchMark® deters idea theft and enables creatives to get paid by providing a trusted way to share and license ideas with prospects and clients.

 

View original content:https://www.prnewswire.com/apac/news-releases/world-ip-day-2026-pitchmark-launches-ideasexchange-to-help-creators-safeguard-and-license-ideas-in-the-age-of-ai-302753571.html

SOURCE PitchMark

Continue Reading

Technology

SK hynix receives 2026 IEEE Corporate Innovation Award for Driving AI Computing Expansion with HBM

Published

2 hours ago

on

April 26, 2026

By

SK hynix honored at the 2026 IEEE Awards for leading AI technology innovation with HBM Contributed to the global AI computing ecosystem via stable mass production across all HBM generationsCompany committed to becoming a premier leader in AI innovation through collaboration with global customers and partners

SEOUL, South Korea, April 25, 2026 /PRNewswire/ — SK hynix Inc. (or “the company”, www.skhynix.com) announced today that it received the Corporate Innovation Award at the ‘2026 IEEE1 Honors Ceremony’ held in New York on the 24th (local time).

IEEE is the world’s largest technical professional organization dedicated to advancing technology for the benefit of humanity. Established more than a century ago, the IEEE Awards Program recognizes individuals and teams whose innovations have advanced technology and improved the human condition.

The IEEE Corporation Innovation Award, part of the Recognitions category, has been presented since 1986 to companies that have significantly contributed to the advancement of industry and society through innovative technology. This marks the first time SK hynix has received this honor.

SK hynix attributed the honor to its contribution to the global AI computing ecosystem by ensuring the stable mass production of all High Bandwidth Memory (HBM) generations. Looking ahead, the company aims to solidify its position as a trusted partner in the global AI market by providing memory solutions that are critical to overcoming the performance limitations of AI platforms.

The recognition highlights SK hynix’s achievements in driving the expansion of AI computing through HBM innovation and application. Central to this success was the company’s ability to preemptively offer innovative HBM solutions and respond timely to customer demands in the global AI market.

Industry observers also credit this achievement to the strategic direction of SK Group Chairman Chey Tae-won, who has long emphasized securing long-term technological competitiveness. Under his leadership, the company has consistently expanded its AI infrastructure partnerships with global Big Tech firms in the United States.

Ahn Hyun, President and Chief Development Officer (CDO), attended the ceremony as the company representative to accept the award.

“It is an honor to receive this award on behalf of our employees, who have tirelessly challenged the limits of technology,” said Ahn. “By collaborating closely with our global customers and partners, we will stay ahead in creating the value the market demands and continue to be a premier company leading AI innovation.”

About SK hynix Inc.
SK hynix Inc., headquartered in Korea, is the world’s top-tier semiconductor supplier offering Dynamic Random Access Memory chips (“DRAM”) and flash memory chips (“NAND flash”) for a wide range of distinguished customers globally. The Company’s shares are traded on the Korea Exchange, and the Global Depository shares are listed on the Luxembourg Stock Exchange. Further information about SK hynix is available at www.skhynix.com, news.skhynix.com.

About IEEE
IEEE is the world’s largest technical professional organization and a public charity dedicated to advancing technology for the benefit of humanity. Through its highly cited publications, conferences, technology standards, and professional and educational activities, IEEE is the trusted voice in a wide variety of areas ranging from aerospace systems, computers, and telecommunications to biomedical engineering, electric power, and consumer electronics. Learn more at https://www.ieee.org.

View original content:https://www.prnewswire.com/news-releases/sk-hynix-receives-2026-ieee-corporate-innovation-award-for-driving-ai-computing-expansion-with-hbm-302753615.html

SOURCE SK hynix Inc.

Continue Reading

Technology

NCL (Formerly Natural Cure Labs) Unveils New Brand Identity, Reinforcing Its Position as a Leading Monolaurin Supplement Company

Published

5 hours ago

on

April 25, 2026

By

Natural Cure Labs, one of the most recognized monolaurin supplement brands in the United States, is officially transitioning to NCL – the same company, same formulations, and same science-backed standards, under a streamlined name.

ST. PETERSBURG, Fla., April 25, 2026 /PRNewswire-PRWeb/ — Natural Cure Labs, one of the most recognized monolaurin supplement brands in the United States, is officially transitioning to NCL. The company, founded in 2015, is adopting a streamlined brand identity while maintaining the same formulations, manufacturing standards, team, and commitment to quality its customers have trusted for more than a decade.

“NCL represents the quality, transparency, and innovation that our community expects from us. As we enter this new chapter, our commitment to our customers and our standards remains as strong as ever.”

NCL stands for Natural Cure Labs. The name change reflects how customers and the team already refer to the company. Over the past 10+ years, “NCL” has become the natural shorthand for Natural Cure Labs – and this transition formalizes that identity. This is a name change and visual evolution only. Ownership, leadership, formulations, and values remain unchanged.

Same Mission, Sharper Identity

This transition is not a departure from who the company is – it is a natural progression. The values that have guided NCL from the very beginning remain unchanged: clean-label quality, third-party testing, science-backed formulations, and an unwavering commitment to transparency. What is changing is how the company presents itself. In the months ahead, this rebrand will be accompanied by further updates across the brand experience – from visual identity and packaging to how NCL shows up across every channel and platform. Each of these changes will reflect the same standard of excellence customers have come to expect.

What is changing is how the company presents itself. In the months ahead, this rebrand will be accompanied by further updates across the brand experience – from visual identity and packaging to how NCL shows up across every channel and platform. Each of these changes will reflect the same standard of excellence customers have come to expect.

More Than 10 Years of Trust

This evolution comes at a time of significant momentum. Since 2015, NCL has grown from a small startup into an award-winning wellness brand available nationwide through Amazon, Walmart, Target+, TikTok Shop, eBay, and other major marketplaces. Along the way, the company has reached milestones that reflect the trust its community has placed in it:

200,000+ customers served worldwide35+ million capsules sold7,000+ verified customer reviewsRecognition in the 2025 Inc. 5000 list of fastest-growing private companiesMultiple Stevie Awards from the American Business AwardsNamed a 2025 and 2026 Gator100 HonoreeThree-time Global 100 winner for Best Health & Wellness Nutrition Manufacturer

“This rebrand isn’t about changing who we are – it’s about evolving how we present ourselves to match the brand our customers already know and trust,” said Damon Sununtnasuk, Founder & CEO.

What This Means for Customers

For existing customers, nothing changes about the products they know and trust. The same formulations, manufacturing facilities, quality controls, and customer support team remain in place. Products sold as Natural Cure Labs and products sold as NCL are from the same company. Customers can continue to find NCL products on the company’s website and through Amazon, Walmart, Target+, Kroger, eBay, and other major marketplaces.

NCL is grateful for every customer who has been part of this journey and is excited for what is to come.

Media Contact

NCL (Natural Cure Labs), NCL (Natural Cure Labs), 1 8003036214, press@naturalcurelabs.com, https://www.naturalcurelabs.com/

View original content to download multimedia:https://www.prweb.com/releases/ncl-formerly-natural-cure-labs-unveils-new-brand-identity-reinforcing-its-position-as-a-leading-monolaurin-supplement-company-302753477.html

SOURCE NCL (Natural Cure Labs)

Continue Reading

Trending